Serovera

Serovera is a nutritional supplement marketed by TeamTrade, Inc., designed to help consumers with gastrointestinal disorders and diseases. It is sold at retailers as well as through direct internet marketing.

Currently sold in the United States with the stabilized and isolated agent aloe mucilaginous polysaccharide, it is advertised as “reversing gastrointestinal disorders” and “digestive diseases” like Crohn’s Disease, diverticulitis, ulcerative colitis, and irritable bowel disease. Like many nutraceuticals, its efficacy is questionable [ [http://pt.wkhealth.com/pt/re/alpt/abstract.00001716-200404070-00004.htm;jsessionid=Hnnfdy0Znv4vv3Jl2ds9dWVY4whb1Gw6tmL5yphvCcHhmW5JGgth!1138671057!181195629!8091!-1 "Randomized, double-blind, placebo-controlled trial of oral aloe vera gel for active ulcerative colitis." Blackwell Publishers] ] .

Serovera promotes itself as being created and endorsed by Dr. Ivan Danhof. Various other doctors have contributed and written articles regarding the uses of aloe mucilaginous polysaccharides; Lawrence Plaskett, John C. Pittman, Jeffrey Bland, Julian J. Blitz, James W. Smith and Bruce Eric Hedendal, that support evidence suggesting consumption [ [http://www.simplynaturalproducts.com/article.php?id=9 "Whole-Leaf Aloe Vera, Almost A Panacea By Bruce Eric Hedendal, D.C., Ph.D."] ] of aloe polysaccharides may have a beneficial effect on the body.

Controversy

On October 11th, 2001 120 FDA officials raided an alternative clinic in Tampa and St. Petersburg, Florida for treatment on cancer patients using Albarin, an injectible form of aloe vera. [ [http://www.iahf.com/usa/20011106.html "FDA Raids Florida Alternative Clinic, Treatment Blocked, Lives Jeopardized"] ]

Although Albarin is not an FDA approved drug, DiStefano and Mayer (licensed nutritional counselors whose medical center was raided) had been conducting an Investigational New Research (INR) for its developer, Ivan Danhof of the North Texas University Research Laboratory, in Grand Prairie, Texas into its uses in the treatment of pain in prostate cancer. Danhof had filed an application for an Investigational New Drug (IND) and was on the verge of providing the FDA with data to support this application, when the raid occurred. They were prepared with solid clinical data that Albarin has a powerful immune enhancing effect while blocking the blood supply to cancer cells, causing rapid diminishing of their size and killing them.Fact|date=October 2008

References

External links

* [http://www.serovera.com/ Official Site of Serovera]